Scott Gottlieb
Scott Gottlieb is an American physician. Gottlieb was commissioner of the Food and Drug Administration from 2017 to 2019.[2][3][4][5]
Scott Gottlieb | |
---|---|
Commissioner of the Food and Drug Administration | |
In office May 11, 2017 – April 5, 2019[1] | |
President | Donald Trump |
Preceded by | Robert Califf |
Succeeded by | Stephen Hahn |
Deputy Commissioner of Food and Drugs | |
In office 2005–2007 | |
President | George W. Bush |
Personal details | |
Education | Wesleyan University Mount Sinai School of Medicine |
Gottlieb was a clinical assistant professor at New York University School of Medicine, a resident fellow at the conservative think tank the American Enterprise Institute, and an internist at Tisch Hospital.[6]
Scott Gottlieb Media
References
- ↑ McGinley, Laurie; Bernstein, Lenny (March 5, 2019). FDA Commissioner Gottlieb, who raised alarms about teen vaping, resigns. https://www.washingtonpost.com/health/2019/03/05/fda-commissioner-gottlieb-who-raised-alarms-about-teen-vaping-resigns/. Retrieved March 5, 2019.
- ↑ LaMotte, Sandee (April 4, 2017). Scott Gottlieb: Conflicts surround Trump's FDA pick. CNN. http://www.cnn.com/2017/04/04/health/fda-gottlieb-background-qualifications/. Retrieved 3 May 2017.
- ↑ Neel, Joe (March 10, 2017). "Trump To Nominate Dr. Scott Gottlieb To Head Food And Drug Administration". NPR. Retrieved March 10, 2017.
- ↑ Thomas, Katie, "F.D.A. Official Under Bush Is Said to Be Trump’s Choice to Lead Agency", New York Times, March 10, 2017. Retrieved 2017-03-10.
- ↑ Cunningham, Paige Winfield, "Trump expected to pick Scott Gottlieb to head FDA", Washington Examiner, March 10, 2017. Retrieved 2017-03-10.
- ↑ Dalzell, Michael D. (2011). "A Conversation With Scott Gottlieb, MD: The impact of health care reform on access to biologics, health policy, and managed care". Biotechnology Healthcare. 8 (3): 19–22. PMC 3278114. PMID 22479219.